无容量
易普利姆玛
医学
肝细胞癌
肿瘤科
内科学
实体瘤疗效评价标准
新辅助治疗
癌
化疗
放射科
癌症
免疫疗法
进行性疾病
乳腺癌
作者
Michael LaPelusa,Shadi Chamseddine,Hop S. Tran Cao,Lianchun Xiao,Elshad Hasanov,Priya Bhosale,Hesham M. Amin,Yehia I. Mohamed,Betül Gök Yavuz,Yara Sakr,Li Xu,Ian Hu,Sunyoung S. Lee,Divya Sakamuri,Sonali Jindal,Van Hoang Nguyen,Michael A. Curran,Ryan Sun,Asif Rashid,Dan G. Duda
出处
期刊:Oncology
[Karger Publishers]
日期:2024-10-18
卷期号:103 (6): 490-497
被引量:3
摘要
Changes in tumor size, immune cell infiltration, and immune cell activation are candidate predictive markers of pathologic response to neoadjuvant immunotherapy in patients with resectable HCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI